Natpara

Active Ingredient(s): Parathyroid Hormone
FDA Approved: * January 23, 2015
Pharm Company: * NPS PHARMS INC
Category: Thyroid

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Natpara Overview

Recombinant human parathyroid hormone, marketed under the trade name Natpara, is an artificially manufactured form of the parathyroid hormone used to treat hypoparathyroidism.[1][2] References ^ "FDA approves Natpara to control low blood calcium levels in patients with hypoparathyroidism". fda.gov. Retrieved 30 January 2015..mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free...

Read more Natpara Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Recombinant_human_parathyroid_hormone

Recent Natpara Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Other drugs which contain Parathyroid Hormone or a similar ingredient: (1 result)

• PARATHYROID HORMONE